(Q44661511)

English

Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients

scientific article published on 29 October 2013

Statements

Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients (English)
Simone M Goldinger
Lisa Zimmer
Carsten Schulz
Christoph Hoeller
Katharina C Kaehler
Jessica C Hassel
Juergen Becker
Dermatology Cooperative Oncology Group (DeCOG)
29 October 2013
406-410

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit